Urinary Marker Profiles in Heart Failure with Reduced Versus Preserved Ejection Fraction
© 2023. The Author(s)..
BACKGROUND: Recent data suggest different causes of renal dysfunction between heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF). We therefore studied a wide range of urinary markers reflecting different nephron segments in heart failure patients.
METHODS: In 2070, in chronic heart failure patients, we measured several established and upcoming urinary markers reflecting different nephron segments.
RESULTS: Mean age was 70 ± 12 years, 74% was male and 81% (n = 1677) had HFrEF. Mean estimated glomerular filtration rate (eGFR) was lower in patients with HFpEF (56 ± 23 versus 63 ± 23 ml/min/1.73 m2, P = 0.001). Patients with HFpEF had significantly higher values of NGAL (58.1 [24.0-124.8] versus 28.1 [14.6-66.9] μg/gCr, P < 0.001) and KIM-1 (2.28 [1.49-4.37] versus 1.79 [0.85-3.49] μg/gCr, P = 0.001). These differences were more pronounced in patients with an eGFR > 60 ml/min/1.73m2.
CONCLUSIONS: HFpEF patients showed more evidence of tubular damage and/or dysfunction compared with HFrEF patients, in particular when glomerular function was preserved.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
---|---|
Enthalten in: |
Journal of cardiovascular translational research - 17(2024), 1 vom: 01. Feb., Seite 3-12 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Streng, Koen W [VerfasserIn] |
---|
Links: |
---|
Themen: |
Heart failure |
---|
Anmerkungen: |
Date Completed 28.02.2024 Date Revised 15.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s12265-023-10356-y |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM353018023 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM353018023 | ||
003 | DE-627 | ||
005 | 20240315232611.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s12265-023-10356-y |2 doi | |
028 | 5 | 2 | |a pubmed24n1330.xml |
035 | |a (DE-627)NLM353018023 | ||
035 | |a (NLM)36795286 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Streng, Koen W |e verfasserin |4 aut | |
245 | 1 | 0 | |a Urinary Marker Profiles in Heart Failure with Reduced Versus Preserved Ejection Fraction |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.02.2024 | ||
500 | |a Date Revised 15.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. The Author(s). | ||
520 | |a BACKGROUND: Recent data suggest different causes of renal dysfunction between heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF). We therefore studied a wide range of urinary markers reflecting different nephron segments in heart failure patients | ||
520 | |a METHODS: In 2070, in chronic heart failure patients, we measured several established and upcoming urinary markers reflecting different nephron segments | ||
520 | |a RESULTS: Mean age was 70 ± 12 years, 74% was male and 81% (n = 1677) had HFrEF. Mean estimated glomerular filtration rate (eGFR) was lower in patients with HFpEF (56 ± 23 versus 63 ± 23 ml/min/1.73 m2, P = 0.001). Patients with HFpEF had significantly higher values of NGAL (58.1 [24.0-124.8] versus 28.1 [14.6-66.9] μg/gCr, P < 0.001) and KIM-1 (2.28 [1.49-4.37] versus 1.79 [0.85-3.49] μg/gCr, P = 0.001). These differences were more pronounced in patients with an eGFR > 60 ml/min/1.73m2 | ||
520 | |a CONCLUSIONS: HFpEF patients showed more evidence of tubular damage and/or dysfunction compared with HFrEF patients, in particular when glomerular function was preserved | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Heart failure | |
650 | 4 | |a Proximal tubule | |
650 | 4 | |a Renal function | |
650 | 4 | |a Urinary markers | |
700 | 1 | |a Hillege, Hans L |e verfasserin |4 aut | |
700 | 1 | |a Ter Maaten, Jozine M |e verfasserin |4 aut | |
700 | 1 | |a van Veldhuisen, Dirk J |e verfasserin |4 aut | |
700 | 1 | |a Dickstein, Kenneth |e verfasserin |4 aut | |
700 | 1 | |a Samani, Nilesh J |e verfasserin |4 aut | |
700 | 1 | |a Ng, Leong L |e verfasserin |4 aut | |
700 | 1 | |a Metra, Marco |e verfasserin |4 aut | |
700 | 1 | |a Filippatos, Gerasimos S |e verfasserin |4 aut | |
700 | 1 | |a Ponikowski, Piotr |e verfasserin |4 aut | |
700 | 1 | |a Zannad, Faiez |e verfasserin |4 aut | |
700 | 1 | |a Anker, Stefan D |e verfasserin |4 aut | |
700 | 1 | |a van der Meer, Peter |e verfasserin |4 aut | |
700 | 1 | |a Lang, Chim C |e verfasserin |4 aut | |
700 | 1 | |a Voors, Adriaan A |e verfasserin |4 aut | |
700 | 1 | |a Damman, Kevin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of cardiovascular translational research |d 2008 |g 17(2024), 1 vom: 01. Feb., Seite 3-12 |w (DE-627)NLM18709375X |x 1937-5395 |7 nnns |
773 | 1 | 8 | |g volume:17 |g year:2024 |g number:1 |g day:01 |g month:02 |g pages:3-12 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s12265-023-10356-y |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 17 |j 2024 |e 1 |b 01 |c 02 |h 3-12 |